Jan 7 (Reuters) - The government of Australia has signed an advanced agreement to purchase 51 million doses of Novavax Inc's experimental COVID-19 vaccine, the company disclosed in a regulatory filing on Thursday. (https://bit.ly/35BGW3Z) (Reporting by Trisha Roy in Bengaluru; Editing by Shounak Dasgupta)
Market Closed -
Other stock markets
|
After market 16:19:17 | |||
13.78 USD | -1.89% | 13.71 | -0.54% |
06-14 | Novavax Files Emergency Use Authorization Amendment For Updated COVID-19 Vaccine | MT |
06-14 | FDA asks COVID vaccine makers to target KP.2 strain with updated shots | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+187.19% | 1.97B | |
+34.01% | 52.85B | |
-8.02% | 38.87B | |
+34.86% | 38.24B | |
-11.12% | 26.79B | |
+12.56% | 26.16B | |
-19.62% | 19.9B | |
+39.18% | 13.18B | |
+31.47% | 12.24B | |
-3.40% | 11.79B |
- Stock Market
- Equities
- NVAX Stock
- News Novavax, Inc.
- Novavax : Australia enters agreement to buy 51 mln doses of Novavax's COVID-19 vaccine